Rifampin

ATC Code J04AB02

Rifampin

Definition

A semisynthetic derivative of rifamycin with broad antibacterial activity. Rifampin inhibits DNA-dependent RNA polymerase in susceptible bacteria and is often used in combination with other antibiotics for various infections including tuberculosis.

Also known as L-5103, Rifadin, Rifampicin, RIFAMPIN, Rimactane — per NCIT

Also identified as

Indications

Disease Relation Source
Meningococcal meningitis may prevent MEDRT · Public domain (U.S. Government work)
Tuberculosis may prevent MEDRT · Public domain (U.S. Government work)
Bacterial meningitis may treat MEDRT · Public domain (U.S. Government work)
Brucellosis may treat MEDRT · Public domain (U.S. Government work)
Haemophilus infectious disease may treat MEDRT · Public domain (U.S. Government work)
Legionnaires' disease may treat MEDRT · Public domain (U.S. Government work)
Leprosy may treat MEDRT · Public domain (U.S. Government work)
Staphylococcal infection may treat MEDRT · Public domain (U.S. Government work)
Tuberculosis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Central nervous system may treat a disease of this organ DERIVED · CC BY 4.0
Lungs may treat a disease of this organ DERIVED · CC BY 4.0
Meninx may treat a disease of this organ DERIVED · CC BY 4.0
Nervous system may treat a disease of this organ DERIVED · CC BY 4.0
Respiratory system may treat a disease of this organ DERIVED · CC BY 4.0

5 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.